ALXO
HealthcareALX Oncology Holdings Inc.
$1.97-0.06 (-2.72%)
Prev Close
$2.02
Open
$2.04
High
$2.04
Low
$1.97
Volume
309.8K
Market Cap
$115.8M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at ALX Oncology Holdings Inc. (ALXO) has been dominated by buying, with 3 insider purchases totaling $5.16M and 7 insider sales totaling $14.1K. The most recent insider transaction was by Pinto Shelly (SVP, FINANCE AND CAO), who sold $1.3K worth of shares on Feb 18, 2026. ALX Oncology Holdings Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $115.8M.
Buys (12M)
3
$5.16M
Sells (12M)
7
$14.1K
Net Activity
Net Buyer
$5.14M
Active Insiders
5
last 12 mo
ALXO Price Chart
ALXO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 565 | $2.27 | $1.3K | 0 |
| Feb 17, 2026↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,201 | $2.27 | $5.0K | 0 |
| Feb 2, 2026↗ | GOODMAN COREY S | Director | Buy | 3,184,713 | $1.57 | $5.00M | 0 |
| Jan 6, 2026↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 3,925 | $1.11 | $4.4K | 0 |
| Sep 16, 2025↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Buy | 92,233 | $1.08 | $99.4K | 0 |
| Aug 18, 2025↗ | Shantharam Harish | Chief Financial Officer | Buy | 75,000 | $0.78 | $58.4K | 0 |
| Aug 15, 2025↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,382 | $0.64 | $1.5K | 0 |
| Aug 15, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 611 | $0.64 | $391.28 | 0 |
| Jul 7, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 2,011 | $0.45 | $905.15 | 0 |
| Jun 30, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 1,532 | $0.43 | $658.76 | 0 |
| Feb 19, 2025↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,159 | $1.15 | $2.5K | 0 |
| Feb 19, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 550 | $1.15 | $632.61 | 0 |
| Feb 19, 2025↗ | Pons Jaume | PRESIDENT & CSO | Sell | 1,326 | $1.15 | $1.5K | 0 |
| Jan 6, 2025↗ | Pinto Shelly | Interim CFO | Sell | 2,221 | $1.80 | $4.0K | 0 |
| Dec 30, 2024↗ | Pinto Shelly | Interim CFO | Sell | 1,426 | $1.58 | $2.3K | 0 |
| Dec 30, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 10,796 | $1.58 | $17.1K | 0 |
| Dec 2, 2024↗ | Hemrajani Rekha | Director | Buy | 30,000 | $1.55 | $46.4K | 0 |
| Aug 14, 2024↗ | GARCIA PETER S | CHIEF FINANCIAL OFFICER | Sell | 761 | $2.58 | $2.0K | 0 |
| Aug 14, 2024↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,191 | $2.58 | $5.7K | 0 |
| Aug 14, 2024↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 564 | $2.58 | $1.5K | 0 |
| Aug 14, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 1,937 | $2.58 | $5.0K | 0 |
| Aug 14, 2024↗ | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 1,365 | $2.58 | $3.5K | 0 |
| Jul 11, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $7.90 | $158.1K | 0 |
| Jul 5, 2024↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 1,823 | $5.50 | $10.0K | 0 |
| Jul 1, 2024↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 1,373 | $5.82 | $8.0K | 0 |
| Jul 1, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 10,758 | $5.82 | $62.6K | 0 |
| Jul 1, 2024↗ | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 3,273 | $5.82 | $19.0K | 0 |
| Jun 28, 2024↗ | GARCIA PETER S | CHIEF FINANCIAL OFFICER | Sell | 1,789 | $6.03 | $10.8K | 0 |
| Jun 13, 2024↗ | GARCIA PETER S | CHIEF FINANCIAL OFFICER | Buy | 12,000 | $8.53 | $102.3K | 0 |
| Jun 4, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $8.43 | $168.7K | 0 |
| May 13, 2024↗ | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 12,000 | $15.94 | $191.3K | 0 |
| May 6, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $15.92 | $318.3K | 0 |
| Apr 16, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 50,000 | $14.20 | $710.2K | 0 |
| Apr 4, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $11.15 | $223.0K | 0 |
| Mar 14, 2024↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Buy | 4,400 | $11.31 | $49.8K | 0 |
| Jan 4, 2024↗ | Pinto Shelly | SVP, Finance and CAO | Sell | 2,717 | $13.60 | $37.0K | 0 |
| Dec 29, 2023↗ | GARCIA PETER S | Chief Financial Officer | Sell | 1,893 | $15.04 | $28.5K | 0 |
| Dec 29, 2023↗ | Pinto Shelly | SVP, Finance and CAO | Sell | 1,631 | $15.04 | $24.5K | 0 |
| Dec 29, 2023↗ | Pons Jaume | President & CSO | Sell | 7,179 | $15.04 | $108.0K | 0 |
| Dec 29, 2023↗ | Randolph Sophia | Chief Medical Officer | Sell | 3,128 | $15.04 | $47.0K | 0 |
| Jul 6, 2023↗ | Pinto Shelly | VP, Finance and CAO | Sell | 7,345 | $6.52 | $47.9K | 0 |
| Jun 30, 2023↗ | GARCIA PETER S | Chief Financial Officer | Sell | 887 | $7.34 | $6.5K | 0 |
| Jun 30, 2023↗ | Pinto Shelly | VP, Finance and CAO | Sell | 466 | $7.34 | $3.4K | 0 |
| Jun 30, 2023↗ | Pons Jaume | President & CEO | Sell | 3,208 | $7.34 | $23.5K | 0 |
| Jun 30, 2023↗ | Randolph Sophia | Chief Medical Officer | Sell | 1,605 | $7.34 | $11.8K | 0 |
| Dec 29, 2022↗ | GARCIA PETER S | Chief Financial Officer | Sell | 893 | $11.07 | $9.9K | 0 |
| Dec 29, 2022↗ | Pinto Shelly | VP, Finance and CAO | Sell | 482 | $11.07 | $5.3K | 0 |
| Dec 29, 2022↗ | Pons Jaume | President & CEO | Sell | 3,232 | $11.07 | $35.8K | 0 |
| Dec 29, 2022↗ | Randolph Sophia | Chief Medical Officer | Sell | 1,617 | $11.07 | $17.9K | 0 |
| Dec 13, 2021↗ | Lettmann Jason | Director | Sell | 325,377 | $27.36 | $8.90M | 0 |
Showing 1–50 of 72
1 / 2
ALXO Insider Buying Activity
The following table shows recent insider purchases of ALX Oncology Holdings Inc. (ALXO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026↗ | GOODMAN COREY S | Director | Buy | 3,184,713 | $1.57 | $5.00M | 0 |
| Sep 16, 2025↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Buy | 92,233 | $1.08 | $99.4K | 0 |
| Aug 18, 2025↗ | Shantharam Harish | Chief Financial Officer | Buy | 75,000 | $0.78 | $58.4K | 0 |
| Dec 2, 2024↗ | Hemrajani Rekha | Director | Buy | 30,000 | $1.55 | $46.4K | 0 |
| Jun 13, 2024↗ | GARCIA PETER S | CHIEF FINANCIAL OFFICER | Buy | 12,000 | $8.53 | $102.3K | 0 |
| Mar 14, 2024↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Buy | 4,400 | $11.31 | $49.8K | 0 |
ALXO Insider Selling Activity
The following table shows recent insider sales of ALX Oncology Holdings Inc. (ALXO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 565 | $2.27 | $1.3K | 0 |
| Feb 17, 2026↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,201 | $2.27 | $5.0K | 0 |
| Jan 6, 2026↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 3,925 | $1.11 | $4.4K | 0 |
| Aug 15, 2025↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,382 | $0.64 | $1.5K | 0 |
| Aug 15, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 611 | $0.64 | $391.28 | 0 |
| Jul 7, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 2,011 | $0.45 | $905.15 | 0 |
| Jun 30, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 1,532 | $0.43 | $658.76 | 0 |
| Feb 19, 2025↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,159 | $1.15 | $2.5K | 0 |
| Feb 19, 2025↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 550 | $1.15 | $632.61 | 0 |
| Feb 19, 2025↗ | Pons Jaume | PRESIDENT & CSO | Sell | 1,326 | $1.15 | $1.5K | 0 |
| Jan 6, 2025↗ | Pinto Shelly | Interim CFO | Sell | 2,221 | $1.80 | $4.0K | 0 |
| Dec 30, 2024↗ | Pinto Shelly | Interim CFO | Sell | 1,426 | $1.58 | $2.3K | 0 |
| Dec 30, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 10,796 | $1.58 | $17.1K | 0 |
| Aug 14, 2024↗ | GARCIA PETER S | CHIEF FINANCIAL OFFICER | Sell | 761 | $2.58 | $2.0K | 0 |
| Aug 14, 2024↗ | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | 2,191 | $2.58 | $5.7K | 0 |
| Aug 14, 2024↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 564 | $2.58 | $1.5K | 0 |
| Aug 14, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 1,937 | $2.58 | $5.0K | 0 |
| Aug 14, 2024↗ | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 1,365 | $2.58 | $3.5K | 0 |
| Jul 11, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $7.90 | $158.1K | 0 |
| Jul 5, 2024↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 1,823 | $5.50 | $10.0K | 0 |
| Jul 1, 2024↗ | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 1,373 | $5.82 | $8.0K | 0 |
| Jul 1, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 10,758 | $5.82 | $62.6K | 0 |
| Jul 1, 2024↗ | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 3,273 | $5.82 | $19.0K | 0 |
| Jun 28, 2024↗ | GARCIA PETER S | CHIEF FINANCIAL OFFICER | Sell | 1,789 | $6.03 | $10.8K | 0 |
| Jun 4, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $8.43 | $168.7K | 0 |
| May 13, 2024↗ | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 12,000 | $15.94 | $191.3K | 0 |
| May 6, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $15.92 | $318.3K | 0 |
| Apr 16, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 50,000 | $14.20 | $710.2K | 0 |
| Apr 4, 2024↗ | Pons Jaume | PRESIDENT & CSO | Sell | 20,000 | $11.15 | $223.0K | 0 |
| Jan 4, 2024↗ | Pinto Shelly | SVP, Finance and CAO | Sell | 2,717 | $13.60 | $37.0K | 0 |
| Dec 29, 2023↗ | GARCIA PETER S | Chief Financial Officer | Sell | 1,893 | $15.04 | $28.5K | 0 |
| Dec 29, 2023↗ | Pinto Shelly | SVP, Finance and CAO | Sell | 1,631 | $15.04 | $24.5K | 0 |
| Dec 29, 2023↗ | Pons Jaume | President & CSO | Sell | 7,179 | $15.04 | $108.0K | 0 |
| Dec 29, 2023↗ | Randolph Sophia | Chief Medical Officer | Sell | 3,128 | $15.04 | $47.0K | 0 |
| Jul 6, 2023↗ | Pinto Shelly | VP, Finance and CAO | Sell | 7,345 | $6.52 | $47.9K | 0 |
| Jun 30, 2023↗ | GARCIA PETER S | Chief Financial Officer | Sell | 887 | $7.34 | $6.5K | 0 |
| Jun 30, 2023↗ | Pinto Shelly | VP, Finance and CAO | Sell | 466 | $7.34 | $3.4K | 0 |
| Jun 30, 2023↗ | Pons Jaume | President & CEO | Sell | 3,208 | $7.34 | $23.5K | 0 |
| Jun 30, 2023↗ | Randolph Sophia | Chief Medical Officer | Sell | 1,605 | $7.34 | $11.8K | 0 |
| Dec 29, 2022↗ | GARCIA PETER S | Chief Financial Officer | Sell | 893 | $11.07 | $9.9K | 0 |
| Dec 29, 2022↗ | Pinto Shelly | VP, Finance and CAO | Sell | 482 | $11.07 | $5.3K | 0 |
| Dec 29, 2022↗ | Pons Jaume | President & CEO | Sell | 3,232 | $11.07 | $35.8K | 0 |
| Dec 29, 2022↗ | Randolph Sophia | Chief Medical Officer | Sell | 1,617 | $11.07 | $17.9K | 0 |
| Dec 13, 2021↗ | Lettmann Jason | Director | Sell | 325,377 | $27.36 | $8.90M | 0 |
ALXO Insiders
Similar Stocks to ALXO
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B